Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Type 1 diabetes for at least 12 months and have been using multiple daily insulin injections for at least 6 months
- People whose blood sugar control measure (called HbA1c) is 7.0% or above at the screening visit — there is no upper limit on this value
- People who are able to understand, speak, and read English
- People who are willing to use only lispro or aspart insulin (and no other insulin or new non-insulin diabetes medicines) for the length of the study
- People who use a total of at least 10 units of insulin per day
- People whose doctor believes they will be able to follow the study requirements
Who may not be able to join:
- People who are currently using an insulin pump or a closed-loop insulin delivery system
- People who are unable to give informed consent to take part in research
- People who are currently taking a medicine called hydroxyurea, or who have a medical condition that may require it in the future
- People who are currently using a type of diabetes medicine called SGLT-2 inhibitors or sulfonylureas (people using GLP-1 medicines, pramlintide, or metformin may still be considered, but the dose must have been stable for at least 3 months before joining)
- People who have a tape allergy or a skin condition that would prevent wearing a pump or continuous glucose monitor (CGM)
- People who are pregnant or planning to become pregnant during the study
- People currently on kidney dialysis, or who plan to start dialysis during the study; people with a recent kidney function test (eGFR) result below 30 ml/min are also not eligible
- People who are currently receiving cancer treatment
- People with very significant vision or hearing difficulties that would make it hard to use a CGM and insulin pump
- People with concerns about cognitive ability (confirm with trial site)
- People with a significant psychiatric diagnosis or substance use disorder that, in the investigating doctor's opinion, would affect their ability to take part
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Howard Wolpert, MD, Boston Medical Center
Phone: 617-285-9096
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Glucose time-in-range (TIR) of 70-180 mg/dL
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.